Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials

<div>Network plot comparing the adverse events, recurrence rate, disappearance of mucopurulent bloody stool/abdominal pain/diarrhea/tenesmus, and Mayo score. Each node represents a treatment, connections between nodes represent direct comparisons, and node sizes and the thickness of connections vary according to the number of studies involved in a comparison.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials 

Figure 3 | Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials 